Navigating the complex realm of drug access in paediatric care.

Paediatr Child Health

Faculty of Medicine, University of British Columbia, Vancouver, British Columbia.

Published: October 2021

A Drug Access Navigator (DAN) is a role that has been established in patient care settings with the goal of expediting the process by which patients obtain drugs through the Health Canada Special Access Program (SAP), individual drug companies' patient access programs (PAP), and public and private drug plans. In the paediatric setting, the process of accessing many drugs has grown increasingly complex. The majority of paediatric prescriptions involve 'off-label' drug use. This leads to an increased need for drug access through the SAP and/or PAPs and demonstrates that the need for a DAN may be particularly prominent in the paediatric population. To our knowledge, there is no evidence in the literature of a DAN functioning in a paediatric setting, though there is a demonstrable need. We plan to address this need by introducing a DAN for shared use at BC Children's Hospital, a paediatric tertiary care centre.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448498PMC
http://dx.doi.org/10.1093/pch/pxab001DOI Listing

Publication Analysis

Top Keywords

drug access
12
paediatric setting
8
drug
6
paediatric
6
access
5
navigating complex
4
complex realm
4
realm drug
4
access paediatric
4
paediatric care
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!